These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18516622)

  • 1. Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population.
    Bronstein M; Pisanté A; Yakir B; Darvasi A
    Hum Genet; 2008 Aug; 124(1):101-4. PubMed ID: 18516622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people.
    Klimentidis YC; Lemas DJ; Wiener HH; O'Brien DM; Havel PJ; Stanhope KL; Hopkins SE; Tiwari HK; Boyer BB
    J Diabetes; 2014 May; 6(3):251-9. PubMed ID: 24112421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Uyghur population and genetic susceptibility to type 2 diabetes: potential role for variants in CDKAL1, JAZF1, and IGF1 genes.
    Song M; Zhao F; Ran L; Dolikun M; Wu L; Ge S; Dong H; Gao Q; Zhai Y; Zhang L; Yan Y; Liu F; Yang X; Guo X; Wang Y; Wang W
    OMICS; 2015 Apr; 19(4):230-7. PubMed ID: 25785549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia.
    Sim X; Ong RT; Suo C; Tay WT; Liu J; Ng DP; Boehnke M; Chia KS; Wong TY; Seielstad M; Teo YY; Tai ES
    PLoS Genet; 2011 Apr; 7(4):e1001363. PubMed ID: 21490949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-ethnic fine mapping identifies a novel independent locus at the 3' end of CDKAL1 and novel variants of several susceptibility loci for type 2 diabetes in a Han Chinese population.
    Kuo JZ; Sheu WH; Assimes TL; Hung YJ; Absher D; Chiu YF; Mak J; Wang JS; Kwon S; Hsu CC; Goodarzi MO; Lee IT; Knowles JW; Miller BE; Lee WJ; Juang JM; Wang TD; Guo X; Taylor KD; Chuang LM; Hsiung CA; Quertermous T; Rotter JI; Chen YD
    Diabetologia; 2013 Dec; 56(12):2619-28. PubMed ID: 24013783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cautionary tale: the non-causal association between type 2 diabetes risk SNP, rs7756992, and levels of non-coding RNA, CDKAL1-v1.
    Locke JM; Wei FY; Tomizawa K; Weedon MN; Harries LW
    Diabetologia; 2015 Apr; 58(4):745-8. PubMed ID: 25634229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium.
    Salonen JT; Uimari P; Aalto JM; Pirskanen M; Kaikkonen J; Todorova B; Hyppönen J; Korhonen VP; Asikainen J; Devine C; Tuomainen TP; Luedemann J; Nauck M; Kerner W; Stephens RH; New JP; Ollier WE; Gibson JM; Payton A; Horan MA; Pendleton N; Mahoney W; Meyre D; Delplanque J; Froguel P; Luzzatto O; Yakir B; Darvasi A
    Am J Hum Genet; 2007 Aug; 81(2):338-45. PubMed ID: 17668382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case-control study in Han Chinese.
    Lu F; Qian Y; Li H; Dong M; Lin Y; Du J; Lin Y; Chen J; Shen C; Jin G; Dai J; Hu Z; Shen H
    J Hum Genet; 2012 May; 57(5):320-5. PubMed ID: 22437209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association analysis in african americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies.
    Lewis JP; Palmer ND; Hicks PJ; Sale MM; Langefeld CD; Freedman BI; Divers J; Bowden DW
    Diabetes; 2008 Aug; 57(8):2220-5. PubMed ID: 18443202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value.
    Cauchi S; Meyre D; Durand E; Proença C; Marre M; Hadjadj S; Choquet H; De Graeve F; Gaget S; Allegaert F; Delplanque J; Permutt MA; Wasson J; Blech I; Charpentier G; Balkau B; Vergnaud AC; Czernichow S; Patsch W; Chikri M; Glaser B; Sladek R; Froguel P
    PLoS One; 2008 May; 3(5):e2031. PubMed ID: 18461161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
    Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population.
    Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D
    Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals.
    Bao XY; Peng B; Yang MS
    Mol Biol Rep; 2012 Mar; 39(3):2447-54. PubMed ID: 21643948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
    Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
    BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of type 2 diabetes loci implicates CDKAL1 as a birth weight gene.
    Zhao J; Li M; Bradfield JP; Wang K; Zhang H; Sleiman P; Kim CE; Annaiah K; Glaberson W; Glessner JT; Otieno FG; Thomas KA; Garris M; Hou C; Frackelton EC; Chiavacci RM; Berkowitz RI; Hakonarson H; Grant SF
    Diabetes; 2009 Oct; 58(10):2414-8. PubMed ID: 19592620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent.
    Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG
    Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic architecture of prostate cancer in the Ashkenazi Jewish population.
    Vijai J; Kirchhoff T; Gallagher D; Hamel N; Guha S; Darvasi A; Lencz T; Foulkes WD; Offit K; Klein RJ
    Br J Cancer; 2011 Sep; 105(6):864-9. PubMed ID: 21829199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.
    Peter I; Mitchell AA; Ozelius L; Erazo M; Hu J; Doheny D; Abreu MT; Present DH; Ullman T; Benkov K; Korelitz BI; Mayer L; Desnick RJ;
    BMC Med Genet; 2011 May; 12():63. PubMed ID: 21548950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies.
    Herder C; Rathmann W; Strassburger K; Finner H; Grallert H; Huth C; Meisinger C; Gieger C; Martin S; Giani G; Scherbaum WA; Wichmann HE; Illig T
    Horm Metab Res; 2008 Oct; 40(10):722-6. PubMed ID: 18597214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
    Tabara Y; Osawa H; Kawamoto R; Onuma H; Shimizu I; Miki T; Kohara K; Makino H
    Diabetes; 2009 Feb; 58(2):493-8. PubMed ID: 19033397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.